Market Overview:
The global palmer hyperhidrosis treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of palmer hyperhidrosis, technological advancements in the field of palmer hyperhidrosis treatment, and rising awareness about available treatments for palmer hyperhidrosis. Based on type, the global palmer hyperhidrosis treatment market is segmented into medications, surgical treatments, physiotherapy, and others. The medications segment is further sub-segmented into anticholinergics drugs and botulinum toxin injections. The surgical treatments segment is further sub-segmented into endoscopic thoracic sympathectomy (ETS), microwave thermolysis surgery (MTS), and other surgeries.
Product Definition:
Palmer Hyperhidrosis Treatment is a medical procedure used to treat excessive sweating of the palms. It involves the injection of botulinum toxin into the palms, which reduces sweating by blocking nerve signals to the sweat glands. Palmer Hyperhidrosis Treatment is important because it can help improve quality of life for people who suffer from excessive sweating of the hands.
Medications:
Palmer Hyperhidrosis is caused due to excessive sweating in palms, soles, armpits or any other part of the body. This condition is more commonly found in women as compared to men. It generally affects people during their 20's and 30's and gets cured by itself after 40’s owing to hormonal changes.
Surgical Treatments:
Palmer Hyperhidrosis Treatment is surgical procedures that are done to reduce excessive sweating. There are two types of treatments namely Surgical and nonsurgical treatment. Nonsurgical treatment includes topical agents such as antiperspirants, gels, creams or lotions which suppress the urge to sweat through the skin. On the other hand, surgical treatment involves removing parts of nerves that control sweat glands in certain areas of the body such as underarms or palms.
Application Insights:
Primary focal hyperhidrosis is the largest segment and accounted for a share of over 80.0% in 2017. Primary hyperhidrosis is characterized by excessive sweating primarily around the hands, feet or armpits which occurs due to an abnormal excess of eccrine glands in that area. The most common primary foci of palmer syndrome are on the face, neck and chest wall regions. Secondary generalized hyperhidrosis is estimated to be the fastest growing application segment owing to increasing awareness about PGH among individuals suffering from other types of HS as well as their families and friends who care about them deeply. This can be attributed to growing internet usage, especially among millennials population globally who spend more time researching health-related issues online than others do according these studies conducted by Stanford University¢â‚¬â„¢s Center for Health Policy Research (2016).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of technologically advanced products. Moreover, increasing awareness about PALH treatments is expected to fuel growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income and growing patient pool suffering from primary focal hyperhidrosis or generalized palmar hyperhydrosis in this region.
The European market was valued at USD X million in 2017 owing to high incidence rate of primary focal hand sweating among population especially affecting males aged between 15-44 years old group which favored product penetration through direct sales as well as via online pharmacies (e-commerce).
Growth Factors:
- Increasing prevalence of hyperhidrosis
- Growing awareness about the treatment options for hyperhidrosis
- Availability of new and advanced treatment options for hyperhidrosis
- Rising number of clinical studies on hyperhidrosis treatments
- increasing investment in research and development for novel therapies forhyperhidrosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Palmer Hyperhidrosis Treatment Market Research Report
By Type
Medications, Surgical Treatments, Physiotherapy, Others
By Application
Primary Focal Hyperhidrosis, Secondary Generalized Hyperhidrosis
By Companies
Allergan, GlaxoSmithKline, Revance Therapeutics, Ulthera, Inc, TheraVida, Dermira, Inc, Sientra Inc, Medications
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Palmer Hyperhidrosis Treatment Market Report Segments:
The global Palmer Hyperhidrosis Treatment market is segmented on the basis of:
Types
Medications, Surgical Treatments, Physiotherapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Primary Focal Hyperhidrosis, Secondary Generalized Hyperhidrosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- GlaxoSmithKline
- Revance Therapeutics
- Ulthera, Inc
- TheraVida
- Dermira, Inc
- Sientra Inc
- Medications
Highlights of The Palmer Hyperhidrosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medications
- Surgical Treatments
- Physiotherapy
- Others
- By Application:
- Primary Focal Hyperhidrosis
- Secondary Generalized Hyperhidrosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Palmer Hyperhidrosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for hyperhidrosis will vary depending on the individual's symptoms and underlying causes. However, some common treatments for hyperhidrosis include prescription medications such as clonidine or cyproheptadine, topical creams and gels such as apremilast or sebum suppression surgery.
Some of the major players in the palmer hyperhidrosis treatment market are Allergan, GlaxoSmithKline, Revance Therapeutics, Ulthera, Inc, TheraVida, Dermira, Inc, Sientra Inc, Medications.
The palmer hyperhidrosis treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Palmer Hyperhidrosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Palmer Hyperhidrosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Palmer Hyperhidrosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Palmer Hyperhidrosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Palmer Hyperhidrosis Treatment Market Size & Forecast, 2018-2028
4.5.1 Palmer Hyperhidrosis Treatment Market Size and Y-o-Y Growth
4.5.2 Palmer Hyperhidrosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Palmer Hyperhidrosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Palmer Hyperhidrosis Treatment Market Size Forecast by Type
5.2.1 Medications
5.2.2 Surgical Treatments
5.2.3 Physiotherapy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Palmer Hyperhidrosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
6.2.1 Primary Focal Hyperhidrosis
6.2.2 Secondary Generalized Hyperhidrosis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Palmer Hyperhidrosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Palmer Hyperhidrosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Palmer Hyperhidrosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Palmer Hyperhidrosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Palmer Hyperhidrosis Treatment Market Size Forecast by Type
9.6.1 Medications
9.6.2 Surgical Treatments
9.6.3 Physiotherapy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
9.10.1 Primary Focal Hyperhidrosis
9.10.2 Secondary Generalized Hyperhidrosis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Palmer Hyperhidrosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Palmer Hyperhidrosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Palmer Hyperhidrosis Treatment Market Size Forecast by Type
10.6.1 Medications
10.6.2 Surgical Treatments
10.6.3 Physiotherapy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
10.10.1 Primary Focal Hyperhidrosis
10.10.2 Secondary Generalized Hyperhidrosis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Palmer Hyperhidrosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Palmer Hyperhidrosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Palmer Hyperhidrosis Treatment Market Size Forecast by Type
11.6.1 Medications
11.6.2 Surgical Treatments
11.6.3 Physiotherapy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
11.10.1 Primary Focal Hyperhidrosis
11.10.2 Secondary Generalized Hyperhidrosis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Palmer Hyperhidrosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Palmer Hyperhidrosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Palmer Hyperhidrosis Treatment Market Size Forecast by Type
12.6.1 Medications
12.6.2 Surgical Treatments
12.6.3 Physiotherapy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
12.10.1 Primary Focal Hyperhidrosis
12.10.2 Secondary Generalized Hyperhidrosis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Palmer Hyperhidrosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Palmer Hyperhidrosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Palmer Hyperhidrosis Treatment Market Size Forecast by Type
13.6.1 Medications
13.6.2 Surgical Treatments
13.6.3 Physiotherapy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Palmer Hyperhidrosis Treatment Market Size Forecast by Applications
13.10.1 Primary Focal Hyperhidrosis
13.10.2 Secondary Generalized Hyperhidrosis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Palmer Hyperhidrosis Treatment Market: Competitive Dashboard
14.2 Global Palmer Hyperhidrosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 GlaxoSmithKline
14.3.3 Revance Therapeutics
14.3.4 Ulthera, Inc
14.3.5 TheraVida
14.3.6 Dermira, Inc
14.3.7 Sientra Inc
14.3.8 Medications
